News archive

A Q&A with Bryan Laffitte, who leads a Novartis team that’s using the tools of genetic medicine to innovate new therapies for neuromuscular and neurodegenerative conditions.

Novartis is proud to share that TIME has recognized Victor Bultó and Thierry Diagana among the most influential people shaping the future of health. Learn more about what drives our honorees.

The creation of a 700,000-square-foot flagship manufacturing hub marks the continuation of our investment in the US, enabling us to more reliably reach patients across the country.

As Novartis expands its manufacturing capabilities, our new Carlsbad facility will help deliver time-sensitive cancer treatments to patients, meeting future demand.

Learn how community-driven partnerships are helping to break down barriers and support access to health care.

Radioligand therapies harness the power of radioisotopes to target cancer with precision. For Matt Baca, delivering a dose in a three-to-five-day window is all in a day’s work.

At this award-winning two-day event, more than 150 high school students gathered to acquire professional skills that will empower them to lead successful futures.

Creating truly equal care for patients with advanced prostate cancer begins by learning from those often overlooked and help them feel seen, heard, and understood.

In this interview, Katie shares the experiences that have shaped her leadership philosophy, her vision for pioneering new approaches in patient support, and why she believes the future of healthcare lies in combining technological innovation with genuine connection. 

High Lp(a) is an inherited condition that can independently increase the risk of heart disease^1,2,3. Read on.

How do women’s feelings about their breasts impact breast health? We asked 3000 women in the first ever Novartis Breast Health & Experience Index.